Los Altos, CA, United States of America

David A Karlin

USPTO Granted Patents = 5 

Average Co-Inventor Count = 2.7

ph-index = 2

Forward Citations = 49(Granted Patents)


Company Filing History:


Years Active: 1999-2012

Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of David A. Karlin

Introduction

David A. Karlin is a notable inventor based in Los Altos, California. He has made significant contributions to the field of cancer treatment, particularly through his work with the anti-cancer drug picoplatin. With a total of five patents to his name, Karlin's innovations have the potential to impact the lives of many patients suffering from colorectal cancer.

Latest Patents

One of Karlin's latest patents focuses on the use of picoplatin to treat colorectal cancer. This invention provides a method of treatment that involves the administration of picoplatin in conjunction with 5-FU and leucovorin. The patent outlines various treatment regimens, dosages, dosing schedules, and ancillary treatments that can enhance the effectiveness of this therapy.

Career Highlights

Throughout his career, David A. Karlin has worked with several prominent companies in the pharmaceutical industry. Notably, he has been associated with Poniard Pharmaceuticals, Inc. and Sciclone Pharmaceuticals, Inc. His work in these organizations has allowed him to develop and refine his innovative approaches to cancer treatment.

Collaborations

Karlin has collaborated with several esteemed colleagues in his field, including Hazel B. Breitz and Paul L. Weiden. These partnerships have contributed to the advancement of his research and the successful development of his patents.

Conclusion

David A. Karlin's contributions to cancer treatment through his innovative use of picoplatin exemplify the impact that dedicated inventors can have on healthcare. His work continues to pave the way for new treatment options for colorectal cancer patients.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…